跳至主要内容
临床试验/EUCTR2016-005031-32-FI
EUCTR2016-005031-32-FI进行中(未招募)1 期

Metformin use to improve pregnancy outcome in women with type 1 diabetes. A double-blind placebo-controlled multicenter study.

Pirkanmaan sairaanhoitopiiri0 个研究点目标入组 200 人开始时间: 2017年9月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • A pregnancy of a women dealing with type 1 diabetes.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 200
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria for the study are a twin pregnancy, another significant underlying disease, severe complications of diabetes, substance abuse problems, smoking, underweight or strong early pregnancy nausea.

研究者

发起方
Pirkanmaan sairaanhoitopiiri

相似试验

Does metformin improve pregnancy outcome used by... | 临床试验